GUD.TO
Knight Therapeutics Inc
Price:  
5.48 
CAD
Volume:  
27,100.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GUD.TO WACC - Weighted Average Cost of Capital

The WACC of Knight Therapeutics Inc (GUD.TO) is 6.3%.

The Cost of Equity of Knight Therapeutics Inc (GUD.TO) is 6.45%.
The Cost of Debt of Knight Therapeutics Inc (GUD.TO) is 7.35%.

Range Selected
Cost of equity 5.10% - 7.80% 6.45%
Tax rate 22.30% - 26.90% 24.60%
Cost of debt 6.80% - 7.90% 7.35%
WACC 5.1% - 7.6% 6.3%
WACC

GUD.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.28 0.52
Additional risk adjustments 0.5% 1.0%
Cost of equity 5.10% 7.80%
Tax rate 22.30% 26.90%
Debt/Equity ratio 0.13 0.13
Cost of debt 6.80% 7.90%
After-tax WACC 5.1% 7.6%
Selected WACC 6.3%